Systemic dissemination of glioblastoma: literature review

Imagem de Miniatura
Arquivos
art_CARVALHO_Systemic_dissemination_of_glioblastoma_literature_review_2019.PDF (264.24 KB)
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2019
Editora
ASSOC MEDICA BRASILEIRA
DOI
Indexadores
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
CARVALHO, Juliana Arcangelo Di Vita
MALDAUN, Marcos Vinicius Calfat
MORAES, Fabio Y.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.65, n.3, p.460-468, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
INTRODUCTION: Glioblastoma (GBM) is the most frequent primary malignant tumor from the central nervous system in adults. However, the presence of systemic metastasis is an extremely rare event. The objective of this study was to review the literature, evaluating the possible biological mechanisms related to the occurrence of systemic metastasis in patients diagnosed with GBM. RESULTS: The mechanisms that may be related to GBM systemic dissemination are the blood-brain barrier breach, often seen in GBM cases, by the tumor itself or by surgical procedures, gaining access to blood and lymphatic vessels, associated with the acquisition of mesenchymal features of invasiveness, resistance to the immune mechanisms of defense and hostile environment through quiescence. CONCLUSIONS: Tumor cells must overcome many obstacles until the development of systemic metastasis. The physiologic mechanisms are not completely clear. Although not fully understood, the pathophysiological understanding of the mechanisms that may be associated with the systemic spread is salutary for a global understanding of the disease. In addition, this knowledge may be used as a basis for a therapy to be performed in patients diagnosed with GBM distant metastasis.
Palavras-chave
glioblastoma, systemic metastasis, distant metastasis, extracranial, extraneural
URI
https://observatorio.fm.usp.br/handle/OPI/31870
Referências
  1. Adamski V, 2017, ONCOTARGET, V8, P108064, DOI 10.18632/oncotarget.22514
  2. Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590
  3. Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028
  4. Anghileri E, 2016, NEUROSURG REV, V39, P45
  5. Armanios MY, 2004, NEURO-ONCOLOGY, V6, P259, DOI 10.1215/S115285173000474
  6. Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
  7. Beauchesne Patrick, 2011, Cancers (Basel), V3, P461, DOI 10.3390/cancers3010461
  8. CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893
  9. COLQUHOUN SD, 1994, TRANSPLANTATION, V57, P970
  10. Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7
  11. Davis L, 1928, Ann Surg, V87, P8
  12. Dissing-Olesen L, 2015, EBIOMEDICINE, V2, P776, DOI 10.1016/j.ebiom.2015.08.019
  13. Dunn GP, 2012, NEUROSURGERY, V71, P201, DOI 10.1227/NEU.0b013e31824f840d
  14. Elena A, 2016, NEUROSURG REV, V39, P37, DOI 10.1007/s10143-015-0656-9
  15. Endaya BB, 2016, MOL ONCOL, V10, P126, DOI 10.1016/j.molonc.2015.09.001
  16. Forsyth TM, 2015, J CLIN NEUROSCI, V22, P1521, DOI 10.1016/j.jocn.2015.03.018
  17. Frank S, 1998, LANCET, V352, P31, DOI 10.1016/S0140-6736(98)24027-X
  18. Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627
  19. Garcia JR, 2017, REV ESP MED NUCL IMA, V36, P271, DOI 10.1016/j.remn.2016.08.004
  20. Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
  21. Hata N, 2001, NEUROL SURG TOKYO, V29, P433
  22. Houston SC, 2000, INT J RADIAT ONCOL, V48, P831, DOI 10.1016/S0360-3016(00)00662-3
  23. Jager D, 2001, CANCER RES, V61, P2055
  24. Johansen MD, 2016, CASE REP ONCOL MED, DOI 10.1155/2016/8190950
  25. Jonas S, 1996, TRANSPLANT INT, V9, P426, DOI 10.1111/j.1432-2277.1996.tb00903.x
  26. Khattab MH, 2015, CASE REP ONCOL MED, DOI 10.1155/2015/431819
  27. Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309
  28. Kumar V, 2015, J PEDIATR NEUROSCI, V10, P386, DOI 10.4103/1817-1745.174458
  29. Kup PG, 2016, MOL CLIN ONCOL, V5, P437, DOI 10.3892/mco.2016.991
  30. Laraqui L, 2001, Rev Pneumol Clin, V57, P225
  31. Lewis GD, 2017, CNS ONCOL
  32. Li Z, 2010, J NEURO-ONCOL, V97, P451, DOI 10.1007/s11060-009-0044-9
  33. Lianidou ES, 2016, MOL ONCOL, V10, P431, DOI 10.1016/j.molonc.2016.01.011
  34. Liu JY, 2015, CURR PHARM DESIGN, V21, P3032, DOI 10.2174/1381612821666150514105741
  35. Lombard A, 2015, STEM CELLS INT, DOI 10.1155/2015/182985
  36. Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
  37. Lun M, 2011, J NEURO-ONCOL, V105, P261, DOI 10.1007/s11060-011-0575-8
  38. Mihm MC, 1996, LAB INVEST, V74, P43
  39. MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
  40. Mondin V, 2010, EUR ARCH OTO-RHINO-L, V267, P1657, DOI 10.1007/s00405-010-1357-1
  41. MORSE JH, 1990, TRANSPLANTATION, V50, P875, DOI 10.1097/00007890-199011000-00026
  42. Mourad PD, 2005, SURG NEUROL, V63, P511, DOI 10.1016/j.surneu.2004.08.062
  43. Muller C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009095
  44. Narayan A, 2015, NEURORADIOL J, V28, P536, DOI 10.1177/1971400915609348
  45. Nauen DW, 2014, DIAGN CYTOPATHOL, V42, P619, DOI 10.1002/dc.22993
  46. Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068
  47. Ohtani Haruo, 2007, Cancer Immun, V7, P4
  48. Ostrom QT, 2016, NEURO-ONCOLOGY, V18, pv1, DOI 10.1093/neuonc/now207
  49. PENN I, 1991, TRANSPLANT P, V23, P1101
  50. PENN I, 1989, Critical Reviews in Oncogenesis, V1, P27
  51. Pietschmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121592
  52. Ray A, 2015, MOL CLIN ONCOL, V3, P479, DOI 10.3892/mco.2015.494
  53. RUIZ JC, 1993, TRANSPLANTATION, V55, P682
  54. Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102
  55. Savagner P, 2015, CURR TOP DEV BIOL, V112, P273, DOI 10.1016/bs.ctdb.2014.11.021
  56. Senetta R, 2011, TUMORS CENTRAL NER 2, V2, P143
  57. Senft D, 2016, PIGM CELL MELANOMA R, V29, P27, DOI 10.1111/pcmr.12432
  58. Starnoni Daniele, 2016, Surg Neurol Int, V7, pS1028, DOI 10.4103/2152-7806.195588
  59. Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
  60. Stupp R, 2017, JAMA-J AM MED ASSOC, V318, P2306, DOI 10.1001/jama.2017.18718
  61. Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669
  62. Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
  63. Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
  64. Undabeitia J, 2015, AN SIST SANIT NAVAR, V38, P157
  65. VALBERNAL F, 1993, HUM PATHOL, V24, P1256, DOI 10.1016/0046-8177(93)90224-5
  66. VandenBussche CJ, 2014, ACTA CYTOL, V58, P117, DOI 10.1159/000357025
  67. Xu M, 2016, WORLD NEUROSURG, V90, DOI 10.1016/j.wneu.2016.01.074

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - ODS/03